Abstract 2133: Next-generation sequencing-based MET focal amplification can predict treatment efficacy of MET inhibitors in lung cancer

作者
Chan Xiang,Lianying Guo,Ruiying Zhao,Haohua Teng,Zhou Zhang,Ting Kuang,Xinze Lv,Ting Hou,Chenglin Liu,Wenjie Sun,Haiwei Du,Yuchen Han
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:83 (7_Supplement): 2133-2133
标识
DOI:10.1158/1538-7445.am2023-2133
摘要

Abstract Background: MET amplification (METamp) occurs in 1-5% of treatment-naïve or 5-20% of epidermal growth factor receptor tyrosine kinase inhibitors-treated lung cancers (LC). It is a promising therapeutic target in LC. Although fluorescence in situ hybridization (FISH), next-generation sequencing (NGS), and immunohistochemical staining (IHC) are available for METamp detection, but the most appropriate detection method and criteria for defining METamp are uncertain. Here, we explored the concordance of these three methods in informing METamp status and identified patients likely to benefit from MET inhibitors. Methods: Tissue samples from LC patients who underwent MET detection by FISH, NGS, and IHC tests at Shanghai Chest Hospital were retrospectively collected. MET focal amplification and polysomy by FISH were determined as MET/CEP7 ratio ≥ 2, and < 2 with the average MET signals per cell ≥ 5, respectively. NGS-based MET focal amplification and polysomy were determined with in-house scripts (Burning Rock Biotech). Focal amplification and polysomy were defined as METamp-positive. IHC-based MET positive was determined with H-score ≥ 200. FISH was used as a reference. Results: A total of 231 patients with a median age of 65 years were enrolled. With FISH as reference testing, NGS detection for METamp showed 66.9% (87/130) sensitivity and 95.1% sensitivity (96/101), and IHC had 71.5% (93/130) sensitivity and 91.1% (92/101) specificity. Furthermore, NGS detection for MET focal amplification achieved 87.2% (75/86) sensitivity and 96.6% (140/145) specificity, while MET polysomy detection showed 20.5% (9/44) sensitivity and 98.4% (184/187) specificity. Of 153 treatment-naïve patients, patients with focal amplification (FISH: 16.7%; NGS: 16.3%) had a significantly lower frequency of classic LC oncogene alterations than those with polysomy (FISH: 51.6%, p = 0.001; NGS: 58.3%, p = 0.006) and METamp-negative patients (METneg; FISH: 72.1%, p < 0.001; NGS: 64.1%, p < 0.001). A total of 27 patients had follow-up data. The disease control rate (DCR) to MET inhibitors was 73.1% (19/26) for overall METamp, 81.0% (17/21) for focal amplification, and 40.0% (2/5) for polysomy using FISH results. In contrast, corresponding DCRs using NGS results were 84.2% (16/19), 88.9% (16/18), and 0% (0/1), respectively. Moreover, patients with NGS-based focal amplification had a significantly longer progression-free survival (PFS) than those with polysomy or METneg. Of note, 1 patient with METneg by FISH was determined to harbor focal amplification by NGS and achieved partial response to crizotinib with a PFS of 314 days. Conclusion: Our results suggest that MET focal amplification leads to oncogenic MET addiction and is associated with promising efficacy of MET inhibitors. MET focal amplification by NGS tests might be a feasible and powerful biomarker to identify LC patients who benefit from MET inhibitors. Citation Format: Chan Xiang, Lianying Guo, Ruiying Zhao, Haohua Teng, Zhou Zhang, Ting Kuang, Xinze Lv, Ting Hou, Chenglin Liu, Wenjie Sun, Haiwei Du, Yuchen Han. Next-generation sequencing-based MET focal amplification can predict treatment efficacy of MET inhibitors in lung cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 2133.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小白t73完成签到 ,获得积分10
刚刚
CyberJankin完成签到,获得积分10
刚刚
Matthew发布了新的文献求助10
1秒前
水月发布了新的文献求助10
1秒前
秋风的应助被调皮的以柳采纳,获得10
1秒前
1秒前
执着访文发布了新的文献求助10
1秒前
1秒前
zyw发布了新的文献求助10
1秒前
科研晓熊完成签到 ,获得积分10
2秒前
飞翔的西红柿完成签到,获得积分10
2秒前
妮妮完成签到,获得积分10
2秒前
2秒前
完美冥发布了新的文献求助10
2秒前
吃葡萄不吐葡萄皮的应助被wsc采纳,获得10
2秒前
3秒前
3秒前
陌璇玑完成签到,获得积分10
3秒前
Zoe发布了新的文献求助10
3秒前
smh发布了新的文献求助10
4秒前
亦亦完成签到 ,获得积分10
4秒前
4秒前
任性的羽毛完成签到 ,获得积分10
4秒前
青橙发布了新的文献求助10
5秒前
qiqi0426发布了新的文献求助10
5秒前
Lucas的应助被年轮采纳,获得10
5秒前
5秒前
搜集达人的应助被xiaoX12138采纳,获得10
5秒前
Xiaoyong完成签到,获得积分10
5秒前
carpediem1997发布了新的文献求助10
6秒前
6秒前
Yuan完成签到,获得积分10
6秒前
6秒前
66完成签到,获得积分10
6秒前
naive完成签到,获得积分10
6秒前
Shmily完成签到,获得积分10
6秒前
7秒前
萱萌完成签到,获得积分10
7秒前
鲤鱼完成签到,获得积分10
7秒前
xz完成签到,获得积分10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8160268
求助须知:如何正确求助?哪些是违规求助? 9555328
关于积分的说明 21727231
捐赠科研通 7750062
什么是DOI,文献DOI怎么找? 3427353
关于科研通互助平台的介绍 2552391
邀请新用户注册赠送积分活动 2471707